Related Experiment Video

Updated: Feb 22, 2026

Purification and Transplantation of Myogenic Progenitor Cell Derived Exosomes to Improve Cardiac Function in Duchenne Muscular Dystrophic Mice
08:13

Purification and Transplantation of Myogenic Progenitor Cell Derived Exosomes to Improve Cardiac Function in Duchenne Muscular Dystrophic Mice

Published on: April 10, 2019

6.5K

Exosomes as New Intercellular Mediators in Development and Therapeutics of Cardiomyocyte Hypertrophy

Qi Huang1,2, Benzhi Cai3,4

  • 1Department of Pharmacy, The Affiliated Second Hospital of Harbin Medical University, 157# Baojian Road, Nangang District, Harbin, 150081, Heilongjiang Province, China.

Advances in Experimental Medicine and Biology
|September 23, 2017
PubMed

Insights

Exosomes, tiny vesicles involved in cell communication, play a dual role in myocardial hypertrophy. While some promote this cardiac condition, others, like those from stem cells, offer protection and therapeutic potential.

Area of Science:

  • Cardiology
  • Cell Biology
  • Biochemistry

Background:

  • Myocardial hypertrophy is a cardiac condition resulting from hemodynamic and neurohormonal changes.
  • Pathological hypertrophic growth impairs cardiac function, potentially leading to congestive heart failure.
  • Exosomes are key mediators in cellular communication, influencing cell migration, proliferation, and differentiation.

Purpose of the Study:

  • To explore the role of exosomes in the development and progression of myocardial hypertrophy.
  • To investigate the differential effects of exosomes derived from various cell types on cardiac hypertrophy.
  • To assess the potential of exosomes in the diagnosis and therapy of cardiomyocyte hypertrophy.

Main Methods:

  • Literature review of recent studies on exosomes and myocardial hypertrophy.
  • Analysis of cellular communication pathways involving exosomes in cardiac tissue.
  • Evaluation of protective mechanisms conferred by specific exosome populations.

Main Results:

  • Exosomes derived from cardiac fibroblasts and other tissues contribute to the development of myocardial hypertrophy.
  • Exosomes originating from cardiac progenitor cells and mesenchymal stem cells demonstrate protective effects against myocardial hypertrophy.
  • Exosomes act as crucial intercellular mediators between cardiomyocytes and other cardiac cells.

Conclusions:

  • Exosomes exhibit a complex, context-dependent role in myocardial hypertrophy.
  • Stem cell-derived exosomes hold promise for therapeutic interventions in cardiac hypertrophy.
  • Exosomes represent a significant avenue for the diagnostic and therapeutic strategies targeting cardiomyocyte hypertrophy.

Keywords:
CardiomyocytesExosomesFibroblastMyocardial hypertrophyStem cells

More Related Videos

Author Spotlight: Enhancing Coronary Artery Revascularization05:25

Author Spotlight: Enhancing Coronary Artery Revascularization

Published on: September 15, 2023

1.3K
In Vitro Differentiation of Human Mesenchymal Stem Cells into Functional Cardiomyocyte-like Cells09:05

In Vitro Differentiation of Human Mesenchymal Stem Cells into Functional Cardiomyocyte-like Cells

Published on: August 9, 2017

11.5K

Related Concept Videos

Overview of Exosomes01:36

Overview of Exosomes

Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
3.8K
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.1K
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
510
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
550